# Cybele Microbiome

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/cybele-microbiome

- Industry: Consumer Products
- Headquarters: San Diego, US
- Website: www.cybelemicrobiome.com
- Total disclosed funding: $0.1M
- Latest round: Seed (Jul 2, 2020)
- Investors on record: 3

## About

Cybele Microbiome Inc. is focused on enhancing human health through innovative microbiome research and applications, offering advanced analysis tools and testing products for consumer and healthcare professional use.Cybele Microbiome Inc. is dedicated to microbiome research and was founded in 2017. The company is headquartered in San Diego, US. Founders Brian Jessup and Nicole Scott established the firm, with Nicole Scott serving as CEO. Cybele Microbiome has completed three funding deals, the most recent being a Seed round on July 2, 2020, raising USD 150,000 from Village Global, totaling USD 150,000 raised to date.Cybele Microbiome specializes in innovative solutions aimed at enhancing human health through microbiome research and applications. The company's core offerings include advanced microbiome analysis tools and products designed for both consumers and healthcare professionals. These products facilitate the understanding of individual microbiome compositions and their implications for health, targeting issues such as digestive health, immune function, and overall wellness. Cybele Microbiome has released a range of proprietary testing kits that enable users to analyze their microbiota and receive tailored recommendations based on the findings. The company serves a diverse client base that includes healthcare practitioners, wellness centers, and direct consumers across North America and select markets in Europe and Asia.Cybele Microbiome generates revenue through a combination of direct-to-consumer sales and partnerships with healthcare providers. The company’s flagship product line consists of microbiome testing kits sold at a fixed price, allowing for straightforward transactions between the firm and its customers. Additionally, Cybele Microbiome engages in subscription-based services, where clients receive ongoing analysis and recommendations based on periodic testing. These transactions are structured to ensure consistent engagement with users, providing them with valuable insights into their health. The company's pricing strategy reflects the premium nature of its products, appealing to health-conscious consumers and professionals seeking cutting-edge solutions in the microbiome space.Cybele Microbiome plans to launch new products that enhance their microbiome offerings and are expected to be released in the coming year. The company aims to expand into additional markets in Europe and Asia by the end of 2023. The recent Seed funding of USD 150,000 will support these initiatives, facilitating the development of new products and the scaling of operations to reach new customers.

## Funding rounds

- Seed, Jul 2, 2020 — SOSV, IndieBio
- Seed, Nov 1, 2018, $0.1M — Village Global

## Investors

- Village Global (https://capitalatlas.ai/funds/village-global) — Seed
- SOSV (https://capitalatlas.ai/funds/sosv) — Seed
- IndieBio (https://capitalatlas.ai/funds/indiebio) — Seed